Double Blind Atorvastatin Amlodipine Study

PHASE4CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

July 31, 2001

Study Completion Date

January 31, 2007

Conditions
Angina
Interventions
DRUG

amlodipine

DRUG

atorvastatin

Trial Locations (33)

Unknown

Pfizer Investigational Site, Rijeka

Pfizer Investigational Site, Zagreb

Pfizer Investigational Site, Ostrava-Kunčice

Pfizer Investigational Site, Pilsen

Pfizer Investigational Site, Prague

Pfizer Investigational Site, Příbram

Pfizer Investigational Site, Rokycany

Pfizer Investigational Site, Tallinn

Pfizer Investigational Site, Tartu

Pfizer Investigational Site, Debrecen

Pfizer Investigational Site, Balatonfüred

Pfizer Investigational Site, Berettyóújfalu

Pfizer Investigational Site, Budapest

Pfizer Investigational Site, Zalaegerszeg

Pfizer Investigational Site, Daugavpils

Pfizer Investigational Site, Riga

Pfizer Investigational Site, Valmiera

Pfizer Investigational Site, Baerum Postterminal

Pfizer Investigational Site, Oslo

Pfizer Investigational Site, Bytom

Pfizer Investigational Site, Katowice

Pfizer Investigational Site, Poznan

Pfizer Investigational Site, Warsaw

Pfizer Investigational Site, Brasov

Pfizer Investigational Site, Bucharest

Pfizer Investigational Site, Craiova

Pfizer Investigational Site, Bratislava

Pfizer Investigational Site, Observatory

Pfizer Investigational Site, Parow

Pfizer Investigational Site, Çapa

Pfizer Investigational Site, Bornova/izmir

Pfizer Investigational Site, Samsun

Pfizer Investigational Site

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00159718 - Double Blind Atorvastatin Amlodipine Study | Biotech Hunter | Biotech Hunter